Global Finished Dosage Form Antithrombin Supply, Demand and Key Producers, 2023-2029
The global Finished Dosage Form Antithrombin market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Finished Dosage Form Antithrombin demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Finished Dosage Form Antithrombin, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Finished Dosage Form Antithrombin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Finished Dosage Form Antithrombin total market, 2018-2029, (USD Million)
Global Finished Dosage Form Antithrombin total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Finished Dosage Form Antithrombin total market, key domestic companies and share, (USD Million)
Global Finished Dosage Form Antithrombin revenue by player and market share 2018-2023, (USD Million)
Global Finished Dosage Form Antithrombin total market by Type, CAGR, 2018-2029, (USD Million)
Global Finished Dosage Form Antithrombin total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Finished Dosage Form Antithrombin market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, LFB S.A./rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc. and Lee Biosolutions, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Finished Dosage Form Antithrombin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Finished Dosage Form Antithrombin Market, By Region:
1. How big is the global Finished Dosage Form Antithrombin market?
2. What is the demand of the global Finished Dosage Form Antithrombin market?
3. What is the year over year growth of the global Finished Dosage Form Antithrombin market?
4. What is the total value of the global Finished Dosage Form Antithrombin market?
5. Who are the major players in the global Finished Dosage Form Antithrombin market?
6. What are the growth factors driving the market demand?
This report studies the global Finished Dosage Form Antithrombin demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Finished Dosage Form Antithrombin, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Finished Dosage Form Antithrombin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Finished Dosage Form Antithrombin total market, 2018-2029, (USD Million)
Global Finished Dosage Form Antithrombin total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Finished Dosage Form Antithrombin total market, key domestic companies and share, (USD Million)
Global Finished Dosage Form Antithrombin revenue by player and market share 2018-2023, (USD Million)
Global Finished Dosage Form Antithrombin total market by Type, CAGR, 2018-2029, (USD Million)
Global Finished Dosage Form Antithrombin total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Finished Dosage Form Antithrombin market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, LFB S.A./rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc. and Lee Biosolutions, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Finished Dosage Form Antithrombin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Finished Dosage Form Antithrombin Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Liquid
- Lyophilized
- Diagnostics
- Therapeutics
- Grifols
- LFB S.A./rEVO Biologics Inc.
- Takeda
- Kedrion S.p.A.
- CSL Limited
- Scripps Laboratories Inc.
- Lee Biosolutions
1. How big is the global Finished Dosage Form Antithrombin market?
2. What is the demand of the global Finished Dosage Form Antithrombin market?
3. What is the year over year growth of the global Finished Dosage Form Antithrombin market?
4. What is the total value of the global Finished Dosage Form Antithrombin market?
5. Who are the major players in the global Finished Dosage Form Antithrombin market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Finished Dosage Form Antithrombin Introduction
1.2 World Finished Dosage Form Antithrombin Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Finished Dosage Form Antithrombin Total Market by Region (by Headquarter Location)
1.3.1 World Finished Dosage Form Antithrombin Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Finished Dosage Form Antithrombin Market Size (2018-2029)
1.3.3 China Finished Dosage Form Antithrombin Market Size (2018-2029)
1.3.4 Europe Finished Dosage Form Antithrombin Market Size (2018-2029)
1.3.5 Japan Finished Dosage Form Antithrombin Market Size (2018-2029)
1.3.6 South Korea Finished Dosage Form Antithrombin Market Size (2018-2029)
1.3.7 ASEAN Finished Dosage Form Antithrombin Market Size (2018-2029)
1.3.8 India Finished Dosage Form Antithrombin Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Finished Dosage Form Antithrombin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Finished Dosage Form Antithrombin Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.2 World Finished Dosage Form Antithrombin Consumption Value by Region
2.2.1 World Finished Dosage Form Antithrombin Consumption Value by Region (2018-2023)
2.2.2 World Finished Dosage Form Antithrombin Consumption Value Forecast by Region (2024-2029)
2.3 United States Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.4 China Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.5 Europe Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.6 Japan Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.7 South Korea Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.8 ASEAN Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.9 India Finished Dosage Form Antithrombin Consumption Value (2018-2029)
3 WORLD FINISHED DOSAGE FORM ANTITHROMBIN COMPANIES COMPETITIVE ANALYSIS
3.1 World Finished Dosage Form Antithrombin Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Finished Dosage Form Antithrombin Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Finished Dosage Form Antithrombin in 2022
3.2.3 Global Concentration Ratios (CR8) for Finished Dosage Form Antithrombin in 2022
3.3 Finished Dosage Form Antithrombin Company Evaluation Quadrant
3.4 Finished Dosage Form Antithrombin Market: Overall Company Footprint Analysis
3.4.1 Finished Dosage Form Antithrombin Market: Region Footprint
3.4.2 Finished Dosage Form Antithrombin Market: Company Product Type Footprint
3.4.3 Finished Dosage Form Antithrombin Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Finished Dosage Form Antithrombin Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Finished Dosage Form Antithrombin Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Finished Dosage Form Antithrombin Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Finished Dosage Form Antithrombin Consumption Value Comparison
4.2.1 United States VS China: Finished Dosage Form Antithrombin Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Finished Dosage Form Antithrombin Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Finished Dosage Form Antithrombin Companies and Market Share, 2018-2023
4.3.1 United States Based Finished Dosage Form Antithrombin Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Finished Dosage Form Antithrombin Revenue, (2018-2023)
4.4 China Based Companies Finished Dosage Form Antithrombin Revenue and Market Share, 2018-2023
4.4.1 China Based Finished Dosage Form Antithrombin Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Finished Dosage Form Antithrombin Revenue, (2018-2023)
4.5 Rest of World Based Finished Dosage Form Antithrombin Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Finished Dosage Form Antithrombin Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Finished Dosage Form Antithrombin Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Finished Dosage Form Antithrombin Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Liquid
5.2.2 Lyophilized
5.3 Market Segment by Type
5.3.1 World Finished Dosage Form Antithrombin Market Size by Type (2018-2023)
5.3.2 World Finished Dosage Form Antithrombin Market Size by Type (2024-2029)
5.3.3 World Finished Dosage Form Antithrombin Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Finished Dosage Form Antithrombin Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Diagnostics
6.2.2 Therapeutics
6.3 Market Segment by Application
6.3.1 World Finished Dosage Form Antithrombin Market Size by Application (2018-2023)
6.3.2 World Finished Dosage Form Antithrombin Market Size by Application (2024-2029)
6.3.3 World Finished Dosage Form Antithrombin Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Grifols
7.1.1 Grifols Details
7.1.2 Grifols Major Business
7.1.3 Grifols Finished Dosage Form Antithrombin Product and Services
7.1.4 Grifols Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Grifols Recent Developments/Updates
7.1.6 Grifols Competitive Strengths & Weaknesses
7.2 LFB S.A./rEVO Biologics Inc.
7.2.1 LFB S.A./rEVO Biologics Inc. Details
7.2.2 LFB S.A./rEVO Biologics Inc. Major Business
7.2.3 LFB S.A./rEVO Biologics Inc. Finished Dosage Form Antithrombin Product and Services
7.2.4 LFB S.A./rEVO Biologics Inc. Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 LFB S.A./rEVO Biologics Inc. Recent Developments/Updates
7.2.6 LFB S.A./rEVO Biologics Inc. Competitive Strengths & Weaknesses
7.3 Takeda
7.3.1 Takeda Details
7.3.2 Takeda Major Business
7.3.3 Takeda Finished Dosage Form Antithrombin Product and Services
7.3.4 Takeda Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Takeda Recent Developments/Updates
7.3.6 Takeda Competitive Strengths & Weaknesses
7.4 Kedrion S.p.A.
7.4.1 Kedrion S.p.A. Details
7.4.2 Kedrion S.p.A. Major Business
7.4.3 Kedrion S.p.A. Finished Dosage Form Antithrombin Product and Services
7.4.4 Kedrion S.p.A. Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Kedrion S.p.A. Recent Developments/Updates
7.4.6 Kedrion S.p.A. Competitive Strengths & Weaknesses
7.5 CSL Limited
7.5.1 CSL Limited Details
7.5.2 CSL Limited Major Business
7.5.3 CSL Limited Finished Dosage Form Antithrombin Product and Services
7.5.4 CSL Limited Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 CSL Limited Recent Developments/Updates
7.5.6 CSL Limited Competitive Strengths & Weaknesses
7.6 Scripps Laboratories Inc.
7.6.1 Scripps Laboratories Inc. Details
7.6.2 Scripps Laboratories Inc. Major Business
7.6.3 Scripps Laboratories Inc. Finished Dosage Form Antithrombin Product and Services
7.6.4 Scripps Laboratories Inc. Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Scripps Laboratories Inc. Recent Developments/Updates
7.6.6 Scripps Laboratories Inc. Competitive Strengths & Weaknesses
7.7 Lee Biosolutions
7.7.1 Lee Biosolutions Details
7.7.2 Lee Biosolutions Major Business
7.7.3 Lee Biosolutions Finished Dosage Form Antithrombin Product and Services
7.7.4 Lee Biosolutions Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Lee Biosolutions Recent Developments/Updates
7.7.6 Lee Biosolutions Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Finished Dosage Form Antithrombin Industry Chain
8.2 Finished Dosage Form Antithrombin Upstream Analysis
8.3 Finished Dosage Form Antithrombin Midstream Analysis
8.4 Finished Dosage Form Antithrombin Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Finished Dosage Form Antithrombin Introduction
1.2 World Finished Dosage Form Antithrombin Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Finished Dosage Form Antithrombin Total Market by Region (by Headquarter Location)
1.3.1 World Finished Dosage Form Antithrombin Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Finished Dosage Form Antithrombin Market Size (2018-2029)
1.3.3 China Finished Dosage Form Antithrombin Market Size (2018-2029)
1.3.4 Europe Finished Dosage Form Antithrombin Market Size (2018-2029)
1.3.5 Japan Finished Dosage Form Antithrombin Market Size (2018-2029)
1.3.6 South Korea Finished Dosage Form Antithrombin Market Size (2018-2029)
1.3.7 ASEAN Finished Dosage Form Antithrombin Market Size (2018-2029)
1.3.8 India Finished Dosage Form Antithrombin Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Finished Dosage Form Antithrombin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Finished Dosage Form Antithrombin Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.2 World Finished Dosage Form Antithrombin Consumption Value by Region
2.2.1 World Finished Dosage Form Antithrombin Consumption Value by Region (2018-2023)
2.2.2 World Finished Dosage Form Antithrombin Consumption Value Forecast by Region (2024-2029)
2.3 United States Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.4 China Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.5 Europe Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.6 Japan Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.7 South Korea Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.8 ASEAN Finished Dosage Form Antithrombin Consumption Value (2018-2029)
2.9 India Finished Dosage Form Antithrombin Consumption Value (2018-2029)
3 WORLD FINISHED DOSAGE FORM ANTITHROMBIN COMPANIES COMPETITIVE ANALYSIS
3.1 World Finished Dosage Form Antithrombin Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Finished Dosage Form Antithrombin Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Finished Dosage Form Antithrombin in 2022
3.2.3 Global Concentration Ratios (CR8) for Finished Dosage Form Antithrombin in 2022
3.3 Finished Dosage Form Antithrombin Company Evaluation Quadrant
3.4 Finished Dosage Form Antithrombin Market: Overall Company Footprint Analysis
3.4.1 Finished Dosage Form Antithrombin Market: Region Footprint
3.4.2 Finished Dosage Form Antithrombin Market: Company Product Type Footprint
3.4.3 Finished Dosage Form Antithrombin Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Finished Dosage Form Antithrombin Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Finished Dosage Form Antithrombin Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Finished Dosage Form Antithrombin Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Finished Dosage Form Antithrombin Consumption Value Comparison
4.2.1 United States VS China: Finished Dosage Form Antithrombin Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Finished Dosage Form Antithrombin Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Finished Dosage Form Antithrombin Companies and Market Share, 2018-2023
4.3.1 United States Based Finished Dosage Form Antithrombin Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Finished Dosage Form Antithrombin Revenue, (2018-2023)
4.4 China Based Companies Finished Dosage Form Antithrombin Revenue and Market Share, 2018-2023
4.4.1 China Based Finished Dosage Form Antithrombin Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Finished Dosage Form Antithrombin Revenue, (2018-2023)
4.5 Rest of World Based Finished Dosage Form Antithrombin Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Finished Dosage Form Antithrombin Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Finished Dosage Form Antithrombin Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Finished Dosage Form Antithrombin Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Liquid
5.2.2 Lyophilized
5.3 Market Segment by Type
5.3.1 World Finished Dosage Form Antithrombin Market Size by Type (2018-2023)
5.3.2 World Finished Dosage Form Antithrombin Market Size by Type (2024-2029)
5.3.3 World Finished Dosage Form Antithrombin Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Finished Dosage Form Antithrombin Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Diagnostics
6.2.2 Therapeutics
6.3 Market Segment by Application
6.3.1 World Finished Dosage Form Antithrombin Market Size by Application (2018-2023)
6.3.2 World Finished Dosage Form Antithrombin Market Size by Application (2024-2029)
6.3.3 World Finished Dosage Form Antithrombin Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Grifols
7.1.1 Grifols Details
7.1.2 Grifols Major Business
7.1.3 Grifols Finished Dosage Form Antithrombin Product and Services
7.1.4 Grifols Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Grifols Recent Developments/Updates
7.1.6 Grifols Competitive Strengths & Weaknesses
7.2 LFB S.A./rEVO Biologics Inc.
7.2.1 LFB S.A./rEVO Biologics Inc. Details
7.2.2 LFB S.A./rEVO Biologics Inc. Major Business
7.2.3 LFB S.A./rEVO Biologics Inc. Finished Dosage Form Antithrombin Product and Services
7.2.4 LFB S.A./rEVO Biologics Inc. Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 LFB S.A./rEVO Biologics Inc. Recent Developments/Updates
7.2.6 LFB S.A./rEVO Biologics Inc. Competitive Strengths & Weaknesses
7.3 Takeda
7.3.1 Takeda Details
7.3.2 Takeda Major Business
7.3.3 Takeda Finished Dosage Form Antithrombin Product and Services
7.3.4 Takeda Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Takeda Recent Developments/Updates
7.3.6 Takeda Competitive Strengths & Weaknesses
7.4 Kedrion S.p.A.
7.4.1 Kedrion S.p.A. Details
7.4.2 Kedrion S.p.A. Major Business
7.4.3 Kedrion S.p.A. Finished Dosage Form Antithrombin Product and Services
7.4.4 Kedrion S.p.A. Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Kedrion S.p.A. Recent Developments/Updates
7.4.6 Kedrion S.p.A. Competitive Strengths & Weaknesses
7.5 CSL Limited
7.5.1 CSL Limited Details
7.5.2 CSL Limited Major Business
7.5.3 CSL Limited Finished Dosage Form Antithrombin Product and Services
7.5.4 CSL Limited Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 CSL Limited Recent Developments/Updates
7.5.6 CSL Limited Competitive Strengths & Weaknesses
7.6 Scripps Laboratories Inc.
7.6.1 Scripps Laboratories Inc. Details
7.6.2 Scripps Laboratories Inc. Major Business
7.6.3 Scripps Laboratories Inc. Finished Dosage Form Antithrombin Product and Services
7.6.4 Scripps Laboratories Inc. Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Scripps Laboratories Inc. Recent Developments/Updates
7.6.6 Scripps Laboratories Inc. Competitive Strengths & Weaknesses
7.7 Lee Biosolutions
7.7.1 Lee Biosolutions Details
7.7.2 Lee Biosolutions Major Business
7.7.3 Lee Biosolutions Finished Dosage Form Antithrombin Product and Services
7.7.4 Lee Biosolutions Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Lee Biosolutions Recent Developments/Updates
7.7.6 Lee Biosolutions Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Finished Dosage Form Antithrombin Industry Chain
8.2 Finished Dosage Form Antithrombin Upstream Analysis
8.3 Finished Dosage Form Antithrombin Midstream Analysis
8.4 Finished Dosage Form Antithrombin Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Finished Dosage Form Antithrombin Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Finished Dosage Form Antithrombin Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Finished Dosage Form Antithrombin Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Finished Dosage Form Antithrombin Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Finished Dosage Form Antithrombin Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Finished Dosage Form Antithrombin Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Finished Dosage Form Antithrombin Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Finished Dosage Form Antithrombin Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Finished Dosage Form Antithrombin Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Finished Dosage Form Antithrombin Players in 2022
Table 12. World Finished Dosage Form Antithrombin Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Finished Dosage Form Antithrombin Company Evaluation Quadrant
Table 14. Head Office of Key Finished Dosage Form Antithrombin Player
Table 15. Finished Dosage Form Antithrombin Market: Company Product Type Footprint
Table 16. Finished Dosage Form Antithrombin Market: Company Product Application Footprint
Table 17. Finished Dosage Form Antithrombin Mergers & Acquisitions Activity
Table 18. United States VS China Finished Dosage Form Antithrombin Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Finished Dosage Form Antithrombin Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Finished Dosage Form Antithrombin Companies, Headquarters (States, Country)
Table 21. United States Based Companies Finished Dosage Form Antithrombin Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Finished Dosage Form Antithrombin Revenue Market Share (2018-2023)
Table 23. China Based Finished Dosage Form Antithrombin Companies, Headquarters (Province, Country)
Table 24. China Based Companies Finished Dosage Form Antithrombin Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Finished Dosage Form Antithrombin Revenue Market Share (2018-2023)
Table 26. Rest of World Based Finished Dosage Form Antithrombin Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Finished Dosage Form Antithrombin Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Finished Dosage Form Antithrombin Revenue Market Share (2018-2023)
Table 29. World Finished Dosage Form Antithrombin Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Finished Dosage Form Antithrombin Market Size by Type (2018-2023) & (USD Million)
Table 31. World Finished Dosage Form Antithrombin Market Size by Type (2024-2029) & (USD Million)
Table 32. World Finished Dosage Form Antithrombin Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Finished Dosage Form Antithrombin Market Size by Application (2018-2023) & (USD Million)
Table 34. World Finished Dosage Form Antithrombin Market Size by Application (2024-2029) & (USD Million)
Table 35. Grifols Basic Information, Area Served and Competitors
Table 36. Grifols Major Business
Table 37. Grifols Finished Dosage Form Antithrombin Product and Services
Table 38. Grifols Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Grifols Recent Developments/Updates
Table 40. Grifols Competitive Strengths & Weaknesses
Table 41. LFB S.A./rEVO Biologics Inc. Basic Information, Area Served and Competitors
Table 42. LFB S.A./rEVO Biologics Inc. Major Business
Table 43. LFB S.A./rEVO Biologics Inc. Finished Dosage Form Antithrombin Product and Services
Table 44. LFB S.A./rEVO Biologics Inc. Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. LFB S.A./rEVO Biologics Inc. Recent Developments/Updates
Table 46. LFB S.A./rEVO Biologics Inc. Competitive Strengths & Weaknesses
Table 47. Takeda Basic Information, Area Served and Competitors
Table 48. Takeda Major Business
Table 49. Takeda Finished Dosage Form Antithrombin Product and Services
Table 50. Takeda Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Takeda Recent Developments/Updates
Table 52. Takeda Competitive Strengths & Weaknesses
Table 53. Kedrion S.p.A. Basic Information, Area Served and Competitors
Table 54. Kedrion S.p.A. Major Business
Table 55. Kedrion S.p.A. Finished Dosage Form Antithrombin Product and Services
Table 56. Kedrion S.p.A. Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Kedrion S.p.A. Recent Developments/Updates
Table 58. Kedrion S.p.A. Competitive Strengths & Weaknesses
Table 59. CSL Limited Basic Information, Area Served and Competitors
Table 60. CSL Limited Major Business
Table 61. CSL Limited Finished Dosage Form Antithrombin Product and Services
Table 62. CSL Limited Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. CSL Limited Recent Developments/Updates
Table 64. CSL Limited Competitive Strengths & Weaknesses
Table 65. Scripps Laboratories Inc. Basic Information, Area Served and Competitors
Table 66. Scripps Laboratories Inc. Major Business
Table 67. Scripps Laboratories Inc. Finished Dosage Form Antithrombin Product and Services
Table 68. Scripps Laboratories Inc. Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Scripps Laboratories Inc. Recent Developments/Updates
Table 70. Lee Biosolutions Basic Information, Area Served and Competitors
Table 71. Lee Biosolutions Major Business
Table 72. Lee Biosolutions Finished Dosage Form Antithrombin Product and Services
Table 73. Lee Biosolutions Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 74. Global Key Players of Finished Dosage Form Antithrombin Upstream (Raw Materials)
Table 75. Finished Dosage Form Antithrombin Typical Customers
Table 1. World Finished Dosage Form Antithrombin Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Finished Dosage Form Antithrombin Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Finished Dosage Form Antithrombin Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Finished Dosage Form Antithrombin Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Finished Dosage Form Antithrombin Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Finished Dosage Form Antithrombin Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Finished Dosage Form Antithrombin Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Finished Dosage Form Antithrombin Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Finished Dosage Form Antithrombin Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Finished Dosage Form Antithrombin Players in 2022
Table 12. World Finished Dosage Form Antithrombin Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Finished Dosage Form Antithrombin Company Evaluation Quadrant
Table 14. Head Office of Key Finished Dosage Form Antithrombin Player
Table 15. Finished Dosage Form Antithrombin Market: Company Product Type Footprint
Table 16. Finished Dosage Form Antithrombin Market: Company Product Application Footprint
Table 17. Finished Dosage Form Antithrombin Mergers & Acquisitions Activity
Table 18. United States VS China Finished Dosage Form Antithrombin Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Finished Dosage Form Antithrombin Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Finished Dosage Form Antithrombin Companies, Headquarters (States, Country)
Table 21. United States Based Companies Finished Dosage Form Antithrombin Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Finished Dosage Form Antithrombin Revenue Market Share (2018-2023)
Table 23. China Based Finished Dosage Form Antithrombin Companies, Headquarters (Province, Country)
Table 24. China Based Companies Finished Dosage Form Antithrombin Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Finished Dosage Form Antithrombin Revenue Market Share (2018-2023)
Table 26. Rest of World Based Finished Dosage Form Antithrombin Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Finished Dosage Form Antithrombin Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Finished Dosage Form Antithrombin Revenue Market Share (2018-2023)
Table 29. World Finished Dosage Form Antithrombin Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Finished Dosage Form Antithrombin Market Size by Type (2018-2023) & (USD Million)
Table 31. World Finished Dosage Form Antithrombin Market Size by Type (2024-2029) & (USD Million)
Table 32. World Finished Dosage Form Antithrombin Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Finished Dosage Form Antithrombin Market Size by Application (2018-2023) & (USD Million)
Table 34. World Finished Dosage Form Antithrombin Market Size by Application (2024-2029) & (USD Million)
Table 35. Grifols Basic Information, Area Served and Competitors
Table 36. Grifols Major Business
Table 37. Grifols Finished Dosage Form Antithrombin Product and Services
Table 38. Grifols Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Grifols Recent Developments/Updates
Table 40. Grifols Competitive Strengths & Weaknesses
Table 41. LFB S.A./rEVO Biologics Inc. Basic Information, Area Served and Competitors
Table 42. LFB S.A./rEVO Biologics Inc. Major Business
Table 43. LFB S.A./rEVO Biologics Inc. Finished Dosage Form Antithrombin Product and Services
Table 44. LFB S.A./rEVO Biologics Inc. Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. LFB S.A./rEVO Biologics Inc. Recent Developments/Updates
Table 46. LFB S.A./rEVO Biologics Inc. Competitive Strengths & Weaknesses
Table 47. Takeda Basic Information, Area Served and Competitors
Table 48. Takeda Major Business
Table 49. Takeda Finished Dosage Form Antithrombin Product and Services
Table 50. Takeda Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Takeda Recent Developments/Updates
Table 52. Takeda Competitive Strengths & Weaknesses
Table 53. Kedrion S.p.A. Basic Information, Area Served and Competitors
Table 54. Kedrion S.p.A. Major Business
Table 55. Kedrion S.p.A. Finished Dosage Form Antithrombin Product and Services
Table 56. Kedrion S.p.A. Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Kedrion S.p.A. Recent Developments/Updates
Table 58. Kedrion S.p.A. Competitive Strengths & Weaknesses
Table 59. CSL Limited Basic Information, Area Served and Competitors
Table 60. CSL Limited Major Business
Table 61. CSL Limited Finished Dosage Form Antithrombin Product and Services
Table 62. CSL Limited Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. CSL Limited Recent Developments/Updates
Table 64. CSL Limited Competitive Strengths & Weaknesses
Table 65. Scripps Laboratories Inc. Basic Information, Area Served and Competitors
Table 66. Scripps Laboratories Inc. Major Business
Table 67. Scripps Laboratories Inc. Finished Dosage Form Antithrombin Product and Services
Table 68. Scripps Laboratories Inc. Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Scripps Laboratories Inc. Recent Developments/Updates
Table 70. Lee Biosolutions Basic Information, Area Served and Competitors
Table 71. Lee Biosolutions Major Business
Table 72. Lee Biosolutions Finished Dosage Form Antithrombin Product and Services
Table 73. Lee Biosolutions Finished Dosage Form Antithrombin Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 74. Global Key Players of Finished Dosage Form Antithrombin Upstream (Raw Materials)
Table 75. Finished Dosage Form Antithrombin Typical Customers
LIST OF FIGURES
Figure 1. Finished Dosage Form Antithrombin Picture
Figure 2. World Finished Dosage Form Antithrombin Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Finished Dosage Form Antithrombin Total Market Size (2018-2029) & (USD Million)
Figure 4. World Finished Dosage Form Antithrombin Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Finished Dosage Form Antithrombin Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 13. Finished Dosage Form Antithrombin Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 16. World Finished Dosage Form Antithrombin Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 18. China Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 23. India Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Finished Dosage Form Antithrombin by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Finished Dosage Form Antithrombin Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Finished Dosage Form Antithrombin Markets in 2022
Figure 27. United States VS China: Finished Dosage Form Antithrombin Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Finished Dosage Form Antithrombin Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Finished Dosage Form Antithrombin Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Finished Dosage Form Antithrombin Market Size Market Share by Type in 2022
Figure 31. Liquid
Figure 32. Lyophilized
Figure 33. World Finished Dosage Form Antithrombin Market Size Market Share by Type (2018-2029)
Figure 34. World Finished Dosage Form Antithrombin Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Finished Dosage Form Antithrombin Market Size Market Share by Application in 2022
Figure 36. Diagnostics
Figure 37. Therapeutics
Figure 38. Finished Dosage Form Antithrombin Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
Figure 1. Finished Dosage Form Antithrombin Picture
Figure 2. World Finished Dosage Form Antithrombin Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Finished Dosage Form Antithrombin Total Market Size (2018-2029) & (USD Million)
Figure 4. World Finished Dosage Form Antithrombin Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Finished Dosage Form Antithrombin Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Finished Dosage Form Antithrombin Revenue (2018-2029) & (USD Million)
Figure 13. Finished Dosage Form Antithrombin Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 16. World Finished Dosage Form Antithrombin Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 18. China Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 23. India Finished Dosage Form Antithrombin Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Finished Dosage Form Antithrombin by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Finished Dosage Form Antithrombin Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Finished Dosage Form Antithrombin Markets in 2022
Figure 27. United States VS China: Finished Dosage Form Antithrombin Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Finished Dosage Form Antithrombin Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Finished Dosage Form Antithrombin Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Finished Dosage Form Antithrombin Market Size Market Share by Type in 2022
Figure 31. Liquid
Figure 32. Lyophilized
Figure 33. World Finished Dosage Form Antithrombin Market Size Market Share by Type (2018-2029)
Figure 34. World Finished Dosage Form Antithrombin Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Finished Dosage Form Antithrombin Market Size Market Share by Application in 2022
Figure 36. Diagnostics
Figure 37. Therapeutics
Figure 38. Finished Dosage Form Antithrombin Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source
